More on DRRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+41.7% Growth)
- Ratings (6.4 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/13/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DRRX Cash Flow Statement

Click line-items for a historical chart and %
Net loss -25.7M
Depreciation and amortization 309K
Stock-based compensation 2.02M
Accounts receivable 973K
Inventories -366K
Prepaid expenses and other assets 1.4M
Accounts payable 208K
Accrued and other liabilities 583K
Contract research liability -20K
Deferred revenue 92K
Total adjustments 5.77M
Net cash (used in) provided by operating activities
Purchases of property and equipment -33K
Purchases of available-for-sale securities -24.49M
Proceeds from maturities of available-for-sale securities 26.73M
Proceeds from sales of available-for-sale securities
Net cash provided by (used in) investing activities
Payments on equipment financing obligations -16K
Net proceeds from issuances of common stock 20.57M
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of the period 3.58M
Cash and cash equivalents, end of the period 5.36M